Once the diagnosis of diabetes is made, the PCP should provide the patient with initial MNT guidelines for use until he or she is able to meet with an RD or attend a diabetes-education class. These ...

Taubes (@garytaubes), the bestselling author of Why We Get Fat and Good Calories, Bad Calories, is the author of the new book Rethinking Diabetes: What Science Reveals About Diet, Insulin, and ...

Should pharmacologic treatment of type 2 diabetes start with combination therapy or metformin monotherapy, adding other agents over time? This question was debated at the recent American Diabetes ...

Forms a Wholly-Owned Subsidiary, Convergen Biotech, Inc., to Focus Diabetes Program Development The licensed technologies are based on the same general gene therapy approach under Genprex's original ...

Type 1 diabetes is a chronic autoimmune disease affecting millions of people globally, characterized by the destruction of insulin-producing beta cells in the pancreas. Patients with Type 1 diabetes ...

The U.S. Food and Drug Administration (FDA) recently approved the use of Teplizumab, a new, immunotherapy drug that has been shown to delay the onset of type 1 diabetes by at least two years. The drug ...

The company’s diabetes gene therapy exhibited encouraging preclinical results in both the diabetic mouse model and non-human primate [NHP] model, improving glucose tolerance and reducing insulin ...